Enavate Sciences GP, LLC is an institution, managing $327.5M across 7 long positions as of Q3 2025 with 75% Unknown concentration, with only 7 positions, and 25% allocation to ZBIO.
Largest long holdings in Enavate Sciences GP, LLC's portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Unknown Unknown | $83.5M | 25.49% | — | — 3.8M shares | |
Unknown Unknown | $72.9M | 22.25% | — | 5.61% 2.5M shares | |
Biotechnology Healthcare | $55.8M | 17.05% | — | 5.48% 4.8M shares | |
Unknown Unknown | $46.3M | 14.13% | — | 4.56% 2.5M shares | |
Unknown Unknown | $30.4M | 9.29% | +$30.4M New | 3.32% 2.6M shares | |
Biotechnology Healthcare | $27.3M | 8.32% | — | 4.54% 7.8M shares | |
Unknown Unknown | $11.4M | 3.47% | — | 18.78% 3.8M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Enavate Sciences GP, LLC's latest filing
| Position | Shares Δ |
|---|---|
New |
| Position | Shares Δ |
|---|---|
| No decreased positions | |
Portfolio insights and performance metrics for Enavate Sciences GP, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.